4th Quarter - Report

STANTON PARK GROUP for BARR LABORATORIES

Firm
Client
Income
$30,000
Expenses
—

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

Generic Giologics, HR 1956, S1695, HR1038,HR5629, FDA Reform

LobbyistCovered position, as disclosed
BRIAN CAVEY —
JAMES DERDERIAN —
ANDREW HALATAEI —
ERIN STRAWN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 5629 (110th), H.R. 1038 (110th), H.R. 1956 (110th)

Consumer Issues/Safety/Products CSP

Generic Drug Settlement Issues

LobbyistCovered position, as disclosed
BRIAN CAVEY —
JAMES DERDERIAN —
ANDREW HALATAEI —
ERIN STRAWN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Taxation/Internal Revenue Code TAX

Proposed Bilateral Tax Treaty with Croatia

LobbyistCovered position, as disclosed
BRIAN CAVEY —
JAMES DERDERIAN —
ANDREW HALATAEI —
ERIN STRAWN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Copyright/Patent/Trademark CPT

Patent Reform

LobbyistCovered position, as disclosed
BRIAN CAVEY —
JAMES DERDERIAN —
ANDREW HALATAEI —
ERIN STRAWN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.